Clinical Trials Logo

Filter by:
NCT ID: NCT06254560 Recruiting - Clinical trials for Severe Aplastic Anemia

Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness

Start date: February 23, 2023
Phase: Phase 2
Study type: Interventional

Due to long-term dependence on platelet transfusion, some severe aplastic anemia (SAA) patients suffer platelet transfusion refractoriness (PTR). Unlike immune thrombocytopenia (ITP), glucocorticoids and human immunoglobulin (IVIg) are generally ineffective for PTR. Due to the lack of effective intervention methods, patients with PTR suffer increased platelet transfusions, bleeding events and treatment costs, prolonged hospital stays, and decreased survival rate. SAA with PTR has become a challenge for physicians. The experiment aims to explore the efficacy of rituximab in the treatment of SAA with PTR, and establish a new effective, safe treatment method with relatively low treatment cost.

NCT ID: NCT06254521 Recruiting - Rectal Cancer Clinical Trials

The Effects of Neoadjuvant Tislelizumab Combined With Chemotherapy in Locally Advanced MSS Rectal Cancer

Start date: February 22, 2024
Phase: Phase 2
Study type: Interventional

This study aims to elucidate the effects of neoadjuvant Tislelizumab combined with chemotherapy in locally advanced MSS rectal cancer.

NCT ID: NCT06254508 Recruiting - Obesity Clinical Trials

Online Exercise Program and Dietary Advice (FITT-online) for Children and Adolescents With Obesity

FITT-online
Start date: February 22, 2024
Phase: N/A
Study type: Interventional

This controlled clinical trial aims to compare the effects of an online program that includes exercise guided by the FITT-VP principle and dietary advice, conducted by fitness coaches, in children and adolescents with obesity with a control group that will be enrolled in conventional in-clinic nutrition and exercise advice. All participants will be monitored for 8 months during the active intervention, and followed by 16 months of observation. The study will evaluate the following parameters between groups: BMI, anthropometry, blood biochemistry panel (ALT/AST, lipids, uric acid, HOMA-IR, HbA1c), food frequency questionaire, household survey, satisfaction survey, and adverse events.

NCT ID: NCT06254443 Recruiting - Clinical trials for Acute Lower Gastrointestinal Bleeding

Oral PEG vs. Enema in Urgent Colonoscopy for ALGIB

CANDLE
Start date: January 8, 2024
Phase: N/A
Study type: Interventional

The main goal of this study is to assess whether the diagnostic efficacy of enema is non-inferior to that of oral polyethylene glycol (PEG) in acute lower gastrointestinal bleeding (ALGIB) patients requiring urgent colonoscopy. The secondary objectives include: 1) evaluating potential differences between the enema and oral PEG groups in terms of the difficulty and safety of colonoscopy, as well as exacerbation of bleeding; 2) conducting subgroup analyses to compare the effectiveness of the two bowel preparation methods in specific populations, exploring potential candidate groups for different bowel preparation strategies, and promoting individualized diagnosis and treatment for ALGIB.

NCT ID: NCT06254274 Recruiting - Clinical trials for T2DM (Type 2 Diabetes Mellitus)

A Study of RAY1225 in Participants With Type 2 Diabetes

Start date: February 26, 2024
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with type 2 diabetes mellitus. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.

NCT ID: NCT06254261 Recruiting - Obesity Clinical Trials

A Study of RAY1225 in Participants With Obesity

Start date: February 21, 2024
Phase: Phase 2
Study type: Interventional

The main purpose of this study is to learn more about the Tolerability of RAY1225 in participants with Obesity. The study will also explore the efficacy of RAY1225. The study will last about six months for each participant.

NCT ID: NCT06254235 Completed - Healthy Volunteers Clinical Trials

Bioequivalence Study of Two Octreotide Microsphere Formulations in Healthy Volunteers

Start date: June 16, 2021
Phase: Phase 1
Study type: Interventional

The goal of this clinical trial is to evaluate the pharmacokinetic characteristics of two octreotide microsphere formulations in healthy Chinese volunteers. Participants will receive single-dose of either test or reference octreotide microsphere formulations. Researchers will compare pharmacokinetic characteristics of the two formulations to see if they are bioequivalent.

NCT ID: NCT06254092 Not yet recruiting - Clinical trials for Pulmonary Hypertension

Effect of Tourniquet Binding of Cervical on the Blood Volume of Amniotic Fluid in Cesarean Section

Start date: January 31, 2024
Phase: N/A
Study type: Interventional

This study was conducted to investigate whether the use of tourniquet after delivery of the fetus could reduce the amount of amniotic fluid entering the bloodstream and thus reduce the incidence of intraoperative adverse events.

NCT ID: NCT06254014 Not yet recruiting - Clinical trials for Type 2 Diabetes Mellitus

A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients

Start date: March 1, 2024
Phase: Phase 3
Study type: Interventional

The main purpose of this study is to investigate the efficacy and safety of JY09 versus placebo in patients with type 2 diabetes mellitus (T2DM) inadequately controlled by diet and exercise alone

NCT ID: NCT06253975 Recruiting - Wound Heal Clinical Trials

Randomized, Controlled, Multicenter Study of Extracellular Vesicles From Human Adipose Tissue Promoting Wound Healing

Start date: February 15, 2024
Phase: N/A
Study type: Interventional

By randomly assigning study subjects into groups, interventions with adipose tissue-derived extracellular vesicles (AT-EVs) and placebos are conducted to evaluate whether AT-EVs can promote effective healing of recalcitrant wounds.